SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    International Society for Pharmacoeconomics and Outcomes Research. Pharmacoeconomic Guidelines around the World. Available at http://www.ispor.or./PEguidelines/index.asp (last accessed 29 March 2012).
  • 2
    Rawlins MD. Therapeutics, Evidence and Decision-Making. London: Hodder Arnold, 2011.
  • 3
    Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D'Amico R, Bradburn M, Eastwood AJ. Indirect comparisons of competing interventions. Health Technol Assess 2005; 9.
  • 4
    Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331: 897900.
  • 5
    Song F, Loke YK, Walsh T, Glenny A-M, Eastwood AJ, Altman DG. Methodological problems in the use of indirect comparisons in evaluating healthcare inetrventions: survey of published systematic reviews. BMJ 2009; 338: b1147; doi:10.1136/bmj.b1147.
  • 6
    Donegan S, Williamson P, Gamble C, Tudur-Smith C. Indirect comparisons: a review of reporting and methodological quality. PLoS ONE 2010; 5: e11054.
  • 7
    Ades AE, Mavranezouli I, Dias S, Welton NJ, Whittington C, Kendall T. Network meta-analysis in competing risk outcomes. Value Health 2010; 13: 97683.
  • 8
    Song F, Xiong T, Parekh-Bhurke S, Loke YK, Sutton AJ, Eastwood AJ, Holland R, Chen Y-F, Glenny A-M, Deeks JJ, Altman DG. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ 2011; 343: d4909; doi: 10.1136/bmj.d4909.
  • 9
    National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Clinical Excellence, 2008.
  • 10
    Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2011; 373: 74658.
  • 11
    Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Pirgata M, Spineli LM, Goodwin GM, Geddes JR. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple treatments meta-analysis. Lancet 2011; 378: 130615.
  • 12
    Rawlins MD. Pharmacopolitics and deliberative democracy. Clin Med 2005; 5: 4715.
  • 13
    Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Oxford and New York: Oxford University Press, 2001.
  • 14
    Rawlins MD, Culyer AJ. National Institute for Clinical Excellence and its value judgements. BMJ 2004; 329: 2247.
  • 15
    Rawlins M, Barnett D, Stevens A. Pharmacoeconomics: NICE's approach to decision-making. Br J Clin Pharmacol 2010; 70: 3469.
  • 16
    National Institute for Health and Clinical Excellence. Social Value Judgements: Principles for the Development of Nice's Guidance. London: National Institute for Health and Clinical Excellence, 2008.